The COVID-19 Vaccine, Women’s Menstruation Irregularities & the Need for Conflict-of-Interest-Free Research

On December 1, 2020, Dr. Wolfgang Wodarg and Dr. Michael Yeadon filed a petition to the European Medicines Agency in The Netherlands to request a stay of action for all clinical trials of vaccine candidates designed to stop transmission of or mitigate symptoms of COVID-19. In their Statement of Grounds (see XI), one of their concerns was that there may be the potential for several of the vaccine candidates to induce the formation of humoral antibodies against spike proteins of SARS-CoV2 including antibodies that would act like anti-Syncytin-1 antibodies. Syncytin-1, derived from human endogenous retroviruses (HERV), is responsible for the development of the placenta in mammals and humans and is a prerequisite for a successful pregnancy. In short, one of their many concerns about the COVID-19 vaccine clinical trials, and one of the reasons they were petitioning to have them halted, was because the COVID-19 vaccine candidates had the potential to negatively impact women’s fertility.

Dr. Robert Malone, inventor of mRNA technology, was recently interviewed on Joe Rogan’s podcast (see hour 1:36 minutes) to discuss all things COVID-19. During the 3-hour interview, seen or heard by over 50 million people, Dr. Malone shared his insights on changes in women’s menstruation post-COVID-19 vaccine:

Dr. Robert Malone: “There is a huge number of alterations in menses in women.”

Joe Rogan: “Women go into menopause very young, like I know a girl who is 36 who got the vaccine and hasn’t had her period in eight months.”

Dr. Robert Malone: “Then there are the women post-menopausal that suddenly start bleeding.…What is it that drives menstruation? The ovary. The ovary is the controller through hormones and ovulation.…One of the studies they did do was administer these mRNA complexes to rodents and showed distribution of the synthetic lipid component (the fats that package the RNA)…it goes to the ovary at a very high rate at 11% of the lipids. This wasn’t supposed to happen. It was supposed to stay in the arm when you got jabbed. But it doesn’t. It goes all over the body and it goes to two places that are kind of anomalous: bone marrow and ovaries. The ovarian signal is really clear because it doesn’t happen in the testes.…Think twice about giving these jabs to your kids. Among other things, your girls are born with all the eggs they’ll ever have and these lipids are going to the ovaries and they appear to be affecting menstruation in some way. Menstruation is one of these adverse events. The common variable is spike protein.”

A woman’s menstrual cycle is vital and delicate and may be impacted by menstrual disorders associated with inflammation. As girls and women across the globe are encouraged or mandated to take experimental, zero-liability COVID-19 vaccines, currently under an Emergency Use Authorization, that over one thousand scientific studies prove are dangerous, we must pause and critically assess the situation:

1)    There is no long-term scientific data on the quickly developed COVID-19 vaccines (see Pfizer’s post-marketing report).

2)    There is a 99.41% survival rate if you get COVID-19 and are under age 69, according to Stanford University professors Catherine Axfors and John Ioannidis.

3)    The CDC continues to recommend COVID-19 vaccines for all Americans, age five and older, including pregnant women.

Are people taking the experimental COVID-19 vaccine due to fear, propaganda, and coercion rather than examining the facts? Why? Who is driving the fear, coercion and propaganda?

These questions are important because troubling short-term data have begun to emerge from tens of thousands of girls and women across the globe (see here, here and here) suggesting there is a link between the COVID-19 vaccine and irregular menstrual patterns. Kate Clancy at University of Illinois and Katherine Lee of Washington University School of Medicine have collected more than 140,000 reports of menstrual irregularities after the COVID-19 vaccination as part of their open-ended study on the topic.

This research data is important because COVID-19 vaccine clinical trials do not collect data about menstrual cycles nor is the Vaccine Adverse Event Reporting System (VAERS) in the U.S. set up to collect this data.

In a recent Obstetrics & Gynecology peer-reviewed article titled “Association Between Menstrual Cycle Length and Coronavirus Disease 2019 (COVID-19) Vaccination,” published January 5, 2022, by Alison Edelman, et al., researchers evaluated the menstrual cycles of 2,403 vaccinated women and 1,556 unvaccinated women between the ages of 18-45. They found that the average change in a woman’s menstrual cycle length was statistically significant between vaccinated and unvaccinated women. Vaccinated women experienced a statistically significant increase in the length of their fourth menstrual cycle by 0.64 days compared with their three pre-vaccination cycles. Unvaccinated women noted no significant changes in their fourth cycle during the study, compared to their first three cycles. The researchers* summarized this statistically significant difference between the menstrual cycles of vaccinated and unvaccinated women with a nothing-to-see-here conclusion: “The COVID-19 vaccination is associated with a small change in cycle length but not menses length.”

Because research on menstrual irregularities is vital to the health, fertility and well-being of girls and women around the globe, it is essential scientists who study this topic conduct their work unimpeded by conflicts of interest. Are today’s scientists and university research centers impartial, truth-seeking public servants? Or, are they timid careerists conducting grant-funded science with strings?

*Seven of the eight authors of the study reported conflicts of interest. Alison Edelman, an expert on family planning, and a contributing author to the book Contraceptive Technology, is currently working on a clinical trial sponsored by OHSU in collaboration with the National Institutes of Health (NIH). Alison Edelman reports honoraria and travel reimbursement from ACOG, WHO, and Gynuity for committee activities and honoraria for peer review from the Karolinska Institute, as well as royalties from UpToDate, Inc. Oregon Health & Science University (OHSU), where Alison Edelman is employed, receives research funding from the OHSU Foundation, Merck, HRA Pharma, and NIH for which Alison Edelman is the principal investigator. Co-author Blair G. Darney reports honoraria and travel reimbursement from ACOG and SFP for board, committee, and mentorship activities. Blair G. Darney also receives support from OHSU which receives research funding from Merck/Organon and OPA/DHHS for which Blair G. Darney is the principal investigator. Leo Han receives research funding from the OHSU Foundation which is funded by the Bill & Melinda Gates Foundation, ABOG, ASRM and the NIH for which Leo Han is the principal investigator. Eleonora Benhar, Carlotta Favaro, and Jack T. Pearson are employees of Natural Cycles. Kristen A. Matteson reports honoraria and travel reimbursement from ABOG and travel reimbursement from ACOG. Women & Infants Hospital received funding from Myovant for consulting work done by Kristen A. Matteson on outcomes measures for heavy menstrual bleeding. Emily R. Boniface did not report any potential conflicts of interest.